About Infallible Pharma
Infallible Pharma is a company based in India founded in 2005 by Hari Om. Infallible Pharma has raised $403.65 thousand across 1 funding round from investors including Bharat Shah and Anuradha Bharat Shah. The company has 69 employees as of March 23, 2024. Infallible Pharma offers products and services including Inflorin, IParin, Infamero, and Xzone.
- Headquarter India
- Employees 69 as on 23 Mar, 2024
- Founders Hari Om
- Stage Minicorn
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Infallible Pharma Private Limited
- Date of Incorporation 20 Mar, 2019
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$11.22 M (USD)-34.8as on Mar 31, 2023
-
Net Profit
$285.68 (USD)-99.69as on Mar 31, 2023
-
EBITDA
$136.63 K (USD)-19.14as on Mar 31, 2023
-
Total Equity Funding
$403.65 K (USD)
in 1 rounds
-
Latest Funding Round
$403.65 K (USD), Angel Round
Nov 11, 2021
-
Investors
& 1 more
-
Employee Count
69
as on Mar 23, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Infallible Pharma
Infallible Pharma offers a comprehensive portfolio of products and services, including Inflorin, IParin, Infamero, and Xzone.
Anticoagulant drug for critical care in hospitals.
Anticoagulant product for medical and hospital use.
Antibiotic for treating infections in critical settings.
Antibiotic drug used in hospital critical care.
Funding Insights of Infallible Pharma
Infallible Pharma has successfully raised a total of $403.65K through 1 strategic funding round. The most recent funding activity was a Angel Round of $403.65 thousand completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Infallible Pharma
Infallible Pharma has secured backing from 2 investors, including angel investors. Prominent investors backing the company include Bharat Shah and Anuradha Bharat Shah.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
BS
Bharat Shah |
-
|
Locked | Locked | Locked |
|
AB
Anuradha Bharat Shah |
-
|
Locked | Locked | Locked |
Investor details for Infallible Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Infallible Pharma
Investment portfolio details for Infallible Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Infallible Pharma
Detailed financials for Infallible Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Infallible Pharma Comparisons
Peer comparison for Infallible Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Infallible Pharma
Detailed competitors of Infallible Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Infallible Pharma
Complete news archive for Infallible Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Infallible Pharma
Infallible Pharma was founded in 2005 and raised its 1st funding round 16 years after it was founded.
Infallible Pharma is headquartered in India.
Hari Om is the current CEO of Infallible Pharma. They have also founded this company.
Infallible Pharma is a funded company, having raised a total of $403.65K across 1 funding round to date.
As of Mar 23, 2024, the latest employee count at Infallible Pharma is 69.
Annual revenue of Infallible Pharma is $11.22M as on Mar 31, 2023.
Infallible Pharma, backed by 403650.0 from Bharat Shah, Anuradha Bharat Shah, focuses on providing healthcare solutions, and diversified pharmaceuticals. RD company manufacturing drugs for multiple therapeutic areas. Driving innovation, growth, and excellence in its industry sectors. It continues to evolve, meeting industry challenges with strategic approaches.
Infallible Pharma offers Inflorin, IParin, Infamero, and Xzone.
Infallible Pharma has 2 investors. Key investors include Bharat Shah, and Anuradha Bharat Shah.
The valuation of Infallible Pharma is $4.04M as of Nov 2021.